JS']JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-2. Marginal zone lymphoma (MALT lymphoma/extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue and splenic marginal zone lymphoma)

被引：10
作者：
Kobayashi, Yukio [1 ]
机构：
[1] Int Univ Hlth & Welf, Dept Hematol, Mita Hosp, Minato Ku, 1-4-3 Mita, Tokyo 1088329, Japan
来源：
INTERNATIONAL JOURNAL OF HEMATOLOGY | 2019年 / 110卷 / 04期
关键词：
B-CELL LYMPHOMA; HELICOBACTER-PYLORI INFECTION; NON-HODGKINS-LYMPHOMA; PHASE-II; 1ST-LINE TREATMENT; CLINICAL ACTIVITY; FOLLOW-UP; RITUXIMAB MONOTHERAPY; VILLOUS LYMPHOCYTES; PROGNOSTIC-FACTORS;
D O I：
10.1007/s12185-019-02719-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：393 / 405
页数：13
相关论文
共 72 条
[1]   Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection [J].
Arcaini, Luca ;
Besson, Caroline ;
Frigeni, Marco ;
Fontaine, Helene ;
Goldaniga, Maria ;
Casato, Milvia ;
Visentini, Marcella ;
Torres, Harrys A. ;
Loustaud-Ratti, Veronique ;
Peveling-Oberhag, Jan ;
Fabris, Paolo ;
Rossotti, Roberto ;
Zaja, Francesco ;
Rigacci, Luigi ;
Rattotti, Sara ;
Bruno, Raffaele ;
Merli, Michele ;
Dorival, Celine ;
Alric, Laurent ;
Jaccard, Arnaud ;
Pol, Stanislas ;
Carrat, Fabrice ;
Ferretti, Virginia Valeria ;
Visco, Carlo ;
Hermine, Olivier .
BLOOD, 2016, 128 (21) :2527-2532
[2]  
Asaka M, 2009, JAPANESE J HELICOBAC, V10, P1
[3]  
Asenjo LM, 2007, REV ESP ENFERM DIG, V99, P398
[4]   Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients [J].
Berger, F ;
Felman, P ;
Thieblemont, C ;
Pradier, T ;
Baseggio, L ;
Bryon, PA ;
Salles, G ;
Callet-Bauchu, E ;
Coiffier, B .
BLOOD, 2000, 95 (06) :1950-1956
[5]   Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial [J].
Bertoni, F ;
Conconi, A ;
Capella, C ;
Motta, T ;
Giardini, R ;
Ponzoni, M ;
Pedrinis, E ;
Novero, D ;
Rinaldi, P ;
Cazzaniga, G ;
Biondi, A ;
Wotherspoon, A ;
Hancock, BW ;
Smith, P ;
Souhami, R ;
Cotter, FE ;
Cavalli, F ;
Zucca, E .
BLOOD, 2002, 99 (07) :2541-2544
[6]   A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas [J].
Brown, Jennifer R. ;
Friedberg, Jonathan W. ;
Feng, Yang ;
Scofield, Sarah ;
Phillips, Kimberly ;
Dal Cin, Paola ;
Joyce, Robin ;
Takvorian, Ronald W. ;
Fisher, David C. ;
Fisher, Richard I. ;
Liesveld, Jane ;
Marquis, Diana ;
Neuberg, Donna ;
Freedman, Arnold S. .
BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 (06) :741-748
[7]  
Campo E, 2017, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours, V4th, P263
[8]   Splenic marginal zone lymphoma:: clinical characteristics and prognostic factors in a series of 60 patients [J].
Chacón, JI ;
Mollejo, M ;
Muñoz, E ;
Algara, P ;
Mateo, M ;
Lopez, L ;
Andrade, J ;
Carbonero, IG ;
Martínez, B ;
Piris, MA ;
Cruz, MA .
BLOOD, 2002, 100 (05) :1648-1654
[9]   Non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue [J].
Cohen, Seth M. ;
Petryk, Magdalena ;
Varma, Mala ;
Kozuch, Peter S. ;
Ames, Elizabeth D. ;
Grossbard, Michael L. .
ONCOLOGIST, 2006, 11 (10) :1100-1117
[10]   Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG) [J].
Conconi, A. ;
Martinelli, G. ;
Lopez-Guillermo, A. ;
Zinzani, P. L. ;
Ferreri, A. J. M. ;
Rigacci, L. ;
Devizzi, L. ;
Vitolo, U. ;
Luminari, S. ;
Cavalli, F. ;
Zucca, E. .
ANNALS OF ONCOLOGY, 2011, 22 (03) :689-695
12345678